BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

651 related articles for article (PubMed ID: 19835871)

  • 1. BMP2 accelerates the motility and invasiveness of gastric cancer cells via activation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway.
    Kang MH; Kim JS; Seo JE; Oh SC; Yoo YA
    Exp Cell Res; 2010 Jan; 316(1):24-37. PubMed ID: 19835871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CEACAM6 promotes gastric cancer invasion and metastasis by inducing epithelial-mesenchymal transition via PI3K/AKT signaling pathway.
    Zang M; Zhang B; Zhang Y; Li J; Su L; Zhu Z; Gu Q; Liu B; Yan M
    PLoS One; 2014; 9(11):e112908. PubMed ID: 25398131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The sonic hedgehog signaling pathway stimulates anaplastic thyroid cancer cell motility and invasiveness by activating Akt and c-Met.
    Williamson AJ; Doscas ME; Ye J; Heiden KB; Xing M; Li Y; Prinz RA; Xu X
    Oncotarget; 2016 Mar; 7(9):10472-85. PubMed ID: 26859575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastatic function of BMP-2 in gastric cancer cells: the role of PI3K/AKT, MAPK, the NF-κB pathway, and MMP-9 expression.
    Kang MH; Oh SC; Lee HJ; Kang HN; Kim JL; Kim JS; Yoo YA
    Exp Cell Res; 2011 Jul; 317(12):1746-62. PubMed ID: 21570392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the PI3K/Akt pathway mediates bone morphogenetic protein 2-induced invasion of pancreatic cancer cells Panc-1.
    Chen X; Liao J; Lu Y; Duan X; Sun W
    Pathol Oncol Res; 2011 Jun; 17(2):257-61. PubMed ID: 20848249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. F-box protein 11 promotes the growth and metastasis of gastric cancer via PI3K/AKT pathway-mediated EMT.
    Sun C; Tao Y; Gao Y; Xia Y; Liu Y; Wang G; Gu Y
    Biomed Pharmacother; 2018 Feb; 98():416-423. PubMed ID: 29278851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neogenin-1 Promotes Cell Proliferation, Motility, and Adhesion by Up-Regulation of Zinc Finger E-Box Binding Homeobox 1 Via Activating the Rac1/PI3K/AKT Pathway in Gastric Cancer Cells.
    Qu H; Sun H; Wang X
    Cell Physiol Biochem; 2018; 48(4):1457-1467. PubMed ID: 30064133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PI3K/Akt-dependent phosphorylation of GSK3β and activation of RhoA regulate Wnt5a-induced gastric cancer cell migration.
    Liu J; Zhang Y; Xu R; Du J; Hu Z; Yang L; Chen Y; Zhu Y; Gu L
    Cell Signal; 2013 Feb; 25(2):447-56. PubMed ID: 23123500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor-like domain-containing protein 7 (EGFL7) enhances EGF receptor-AKT signaling, epithelial-mesenchymal transition, and metastasis of gastric cancer cells.
    Luo BH; Xiong F; Wang JP; Li JH; Zhong M; Liu QL; Luo GQ; Yang XJ; Xiao N; Xie B; Xiao H; Liu RJ; Dong CS; Wang KS; Wen JF
    PLoS One; 2014; 9(6):e99922. PubMed ID: 24945379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNF-α induces epithelial-mesenchymal transition of renal cell carcinoma cells via a GSK3β-dependent mechanism.
    Ho MY; Tang SJ; Chuang MJ; Cha TL; Li JY; Sun GH; Sun KH
    Mol Cancer Res; 2012 Aug; 10(8):1109-19. PubMed ID: 22707636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of PI3 kinase/Akt pathway is required for BMP2-induced EMT and invasion.
    Kang MH; Kang HN; Kim JL; Kim JS; Oh SC; Yoo YA
    Oncol Rep; 2009 Sep; 22(3):525-34. PubMed ID: 19639199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blocking PI3K/Akt signaling attenuates metastasis of nasopharyngeal carcinoma cells through induction of mesenchymal-epithelial reverting transition.
    Jiang H; Gao M; Shen Z; Luo B; Li R; Jiang X; Ding R; Ha Y; Wang Z; Jie W
    Oncol Rep; 2014 Aug; 32(2):559-66. PubMed ID: 24889918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Troglitazone ameliorates high glucose-induced EMT and dysfunction of SGLTs through PI3K/Akt, GSK-3β, Snail1, and β-catenin in renal proximal tubule cells.
    Lee YJ; Han HJ
    Am J Physiol Renal Physiol; 2010 May; 298(5):F1263-75. PubMed ID: 20015942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone morphogenetic protein 2 mediates epithelial-mesenchymal transition via AKT and ERK signaling pathways in gastric cancer.
    Liao A; Wang W; Sun D; Jiang Y; Tian S; Li J; Yang X; Shi R
    Tumour Biol; 2015 Apr; 36(4):2773-8. PubMed ID: 25448881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PDGF-D/PDGFRβ promotes tongue squamous carcinoma cell (TSCC) progression via activating p38/AKT/ERK/EMT signal pathway.
    Zhang H; Sun JD; Yan LJ; Zhao XP
    Biochem Biophys Res Commun; 2016 Sep; 478(2):845-51. PubMed ID: 27507215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-Type Lectin-Like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of Phosphoinositide 3-Kinase Subunits.
    Wang L; Yin J; Wang X; Shao M; Duan F; Wu W; Peng P; Jin J; Tang Y; Ruan Y; Sun Y; Gu J
    Gastroenterology; 2016 May; 150(5):1183-1195.e16. PubMed ID: 26855187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimaphilin inhibits human osteosarcoma cell invasion and metastasis through suppressing the TGF-β1-induced epithelial-to-mesenchymal transition markers via PI-3K/Akt, ERK1/2, and Smad signaling pathways.
    Dong F; Liu T; Jin H; Wang W
    Can J Physiol Pharmacol; 2018 Jan; 96(1):1-7. PubMed ID: 28177668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion.
    Shukla S; Maclennan GT; Hartman DJ; Fu P; Resnick MI; Gupta S
    Int J Cancer; 2007 Oct; 121(7):1424-32. PubMed ID: 17551921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C23 protein meditates bone morphogenetic protein-2-mediated EMT via up-regulation of Erk1/2 and Akt in gastric cancer.
    Yang Y; Yang C; Zhang J
    Med Oncol; 2015 Mar; 32(3):76. PubMed ID: 25698539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MMP-9 secreted by tumor associated macrophages promoted gastric cancer metastasis through a PI3K/AKT/Snail pathway.
    Liu L; Ye Y; Zhu X
    Biomed Pharmacother; 2019 Sep; 117():109096. PubMed ID: 31202170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.